MMPs are effectors of BBB disruption [11], and extensive studies in multiple sclerosis and experimental autoimmune encephalomyelitis have highlighted the activities of MMP-2 [19] and MMP-9 [20] in BBB disruption. Here, MMP9 is linked to experimental autoimmune encephalomyelitis.